Enovis Corporation Share Price

Equities

ENOV

US1940145022

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:30:02 02/07/2024 am IST 5-day change 1st Jan Change
44.35 USD -1.88% Intraday chart for Enovis Corporation -1.49% -20.83%
Sales 2024 * 2.12B 177B Sales 2025 * 2.28B 190B Capitalization 2.48B 207B
Net income 2024 * -119M -9.93B Net income 2025 * 54M 4.5B EV / Sales 2024 * 1.72 x
Net Debt 2024 * 1.18B 98.18B Net Debt 2025 * 1.07B 88.99B EV / Sales 2025 * 1.56 x
P/E ratio 2024 *
-32.3 x
P/E ratio 2025 *
42.6 x
Employees 6,550
Yield 2024 *
-
Yield 2025 *
-
Free-Float 94.21%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.88%
1 week-1.49%
Current month-1.88%
1 month-9.78%
3 months-27.80%
6 months-20.00%
Current year-20.83%
More quotes
1 week
44.00
Extreme 44
46.11
1 month
43.80
Extreme 43.8
51.00
Current year
43.80
Extreme 43.8
65.03
1 year
43.04
Extreme 43.04
66.14
3 years
43.04
Extreme 43.04
164.01
5 years
36.69
Extreme 36.69
164.01
10 years
36.69
Extreme 36.69
225.78
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 24/15/24
Director of Finance/CFO 45 01/20/01
Director/Board Member 58 01/19/01
Members of the board TitleAgeSince
Director/Board Member 57 04/22/04
Director/Board Member 53 13/08/13
Director/Board Member 62 15/16/15
More insiders
Date Price Change Volume
02/24/02 44.35 -1.88% 683 013
28/24/28 45.2 +0.65% 916,499
27/24/27 44.91 -0.38% 402,782
26/24/26 45.08 +0.18% 633,755
25/24/25 45 -0.04% 877,967

Delayed Quote Nyse, July 02, 2024 at 01:30 am IST

More quotes
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
45.2 USD
Average target price
72.18 USD
Spread / Average Target
+59.69%
Consensus